Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/9851
Title: Kidney failure associated with liver transplantation or liver failure: the impact of continuous veno-venous hemofiltration.
Authors: Naka, Toshio;Wan, Li;Bellomo, Rinaldo;Wang, B;Jones, R;Berry, R;Angus, Peter W;Gow, Paul J
Affiliation: Department of Intensive Care and Surgery, Austin Hospital, Melbourne, Australia.
Issue Date: 1-Nov-2004
Citation: The International Journal of Artificial Organs; 27(11): 949-55
Abstract: The short-term outcome of critically ill patients with kidney failure combined with severe liver failure or orthotopic liver transplantation (OLTx) is poor. We sought to test the hypothesis that, with the exclusive use of continuous veno-venous hemofilration (CVVH) with minimal heparin-anticoagulation, the short and long-term outcomes of these patients would be improved.Sixty-six consecutive patients with combined liver and kidney failureIntensive Care Unit of tertiary hospitalRetrospective interrogation of prospectively collected databasesTreatment of all patients with continuous veno-venous hemofiltration (CVVH) by protocol with 2L/h of ultrafiltration rate and minimal use of circuit heparinization. Retrieval of specific information on demographic, clinical, therapeutic and outcome details.From July 1995 to April 2004, 66 patients with combined liver and renal failure received continuous veno-venous hemofiltration (CVVH). Of these, 26 received liver transplantation and 40 did not. There were no significant differences in age, APACHE II score, bilirubin, ALT, INR or albumin on admission. The average duration of CVVH was 9.5 days for OLTx patients and 5 days for non-transplanted patients (p=0.013). Heparin anticoagulation was used in only 12% of OLTx patients and 20% of non-transplanted patients. ICU mortality was 15% in OLTx patients and 63% in non-transplanted patients (p<0.0005); hospital mortality was 23% compared to 70% (p<0. 001). Mean survival time at follow up was 1,120 days compared to 358 days (p<0.0001).ARF associated with OLTx has a much better outcome than ARF without OLTx. Furthermore, management based on a conservative anticoagulation policy and CVVH as the exclusive form of renal support was associated with the best ICU, hospital and long term survival reported so far.
Internal ID Number: 15636052
URI: http://ahro.austin.org.au/austinjspui/handle/1/9851
URL: http://www.ncbi.nlm.nih.gov/pubmed/15636052
Type: Journal Article
Subjects: Cause of Death
Critical Illness
Female
Follow-Up Studies
Hemofiltration.methods
Humans
Intensive Care Units
Kidney Failure, Chronic.diagnosis.mortality.therapy
Liver Failure.diagnosis.mortality.therapy
Liver Transplantation.methods.mortality
Male
Probability
Renal Dialysis.methods
Retrospective Studies
Risk Assessment
Statistics, Nonparametric
Survival Analysis
Treatment Outcome
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.